Sunscreening Agent

Pipeline Programs

Companies

Clinical Trials

Approved Products

Pipeline by Development Stage

Preclinical

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

On Market

Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pre

P1/2

P2/3

Mkt

BayerLEVERKUSEN, Germany

11 programs

BAY987517N/A1 trial

CoppertoneN/A1 trial

+6 more programs

Active Trials

NCT02842268Completed15Est. Jun 2016

NCT02822300Completed10Est. Nov 2015

NCT02717351Completed10Est. Mar 2016

+12 more trials

Trial Timeline

Clinical trial activity over time

2021

2022

2023

2024

2025

2026

BayerCoppertone

BayerBAY987517

BayerCoppertone

Showing 15 of 24 trials with date data

Clinical Trials (24)

Total enrollment: 270 patients across 24 trials

NCT03841032 BayerCoppertone

4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness

Start: Jan 2019Est. completion: Feb 201935 patients

N/ACompleted

NCT02842268 BayerBAY987517

Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating

Start: Jun 2016Est. completion: Jun 201615 patients

N/ACompleted

NCT02717351 BayerCoppertone

18841- Sun Protection Factor Assay

Start: Mar 2016Est. completion: Mar 201610 patients

N/ACompleted

NCT02717325 BayerCoppertone

18842 - Sun Protection Factor Assay

Start: Mar 2016Est. completion: Mar 201610 patients

N/ACompleted

NCT02695303 BayerCoppertone

18790 - Sun Protection Factor Assay

Start: Feb 2016Est. completion: Feb 201610 patients

N/ACompleted

NCT02682628 BayerCoppertone

18791 - Sun Protection Factor Assay

Start: Feb 2016Est. completion: Feb 201610 patients

N/ACompleted

NCT02823509 BayerCoppertone

Sun Protection Factor Assay

Start: Dec 2015Est. completion: Dec 201510 patients

N/ACompleted

NCT02825030 BayerCoppertone

Sun Protection Factor Assay (SPF Assay 18676)

Start: Dec 2015Est. completion: Dec 201510 patients

N/ACompleted

NCT02825017 BayerCoppertone

Sun Protection Factor Assay (SPF Assay 18677)

Start: Dec 2015Est. completion: Dec 201510 patients

N/ACompleted

NCT02822313 BayerCoppertone

Sun Protection Factor Assay

Start: Nov 2015Est. completion: Dec 201510 patients

N/ACompleted

NCT02801929 BayerCoppertone

18670 - Sun Protection Factor Assay

Start: Nov 2015Est. completion: Nov 201510 patients

N/ACompleted

NCT02822300 BayerCoppertone

Sun Protection Factor Assay

Start: Nov 2015Est. completion: Nov 201510 patients

N/ACompleted

NCT02822274 BayerCoppertone

Sun Protection Factor Assay

Start: Nov 2015Est. completion: Dec 201510 patients

N/ACompleted

NCT02803099 BayerCoppertone

Sun Protection Factor Assay

Start: Nov 2015Est. completion: Nov 201510 patients

N/ACompleted

NCT02803047 BayerCoppertone

Sun Protection Factor Assay

Start: Nov 2015Est. completion: Nov 201511 patients

N/ACompleted

NCT02803021 BayerCoppertone

Sun Protection Factor Assay

Start: Oct 2015Est. completion: Nov 201510 patients

N/ACompleted

NCT02803008 BayerCoppertone

Sun Protection Factor Assay

Start: Oct 2015Est. completion: Nov 201510 patients

N/ACompleted

NCT02756988 BayerCoppertone

18615 - Sun Protection Factor Assay

Start: Oct 2015Est. completion: Oct 201510 patients

N/ACompleted

NCT02788162 BayerCoppertone

18616 - Sun Protection Factor Assay

Start: Oct 2015Est. completion: Oct 201510 patients

N/ACompleted

NCT02757014 BayerCoppertone

18613 - Sun Protection Factor Assay

Start: Oct 2015Est. completion: Oct 201510 patients

N/ACompleted

NCT02776501 BayerCoppertone

18572 - Sun Protection Factor Assay

Start: Sep 2015Est. completion: Sep 201510 patients

N/ACompleted

NCT02776852 BayerCoppertone

18519 - Sun Protection Factor Assay

Start: Aug 2015Est. completion: Aug 201510 patients

N/ACompleted

NCT02779829 BayerCoppertone

18432-Sun Protection Factor Assay

Start: Jul 2015Est. completion: Sep 201513 patients

N/ACompleted

NCT02779842 BayerCoppertone

Sun Protection Factor - Assay

Start: Jul 2015Est. completion: Aug 20156 patients

N/ACompleted

Phase Legend

Preclinical— Lab & animal studies

Phase 1— Safety & dosing

Phase 2— Efficacy testing

Phase 3— Large-scale trials

On Market— Approved & available

Key Insights

1 companies competing in this space